A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache

NCT05452239 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

608

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine
Medication Overuse Headache

Interventions

DRUG: Eptinezumab
DRUG: Placebo

Sponsor

H. Lundbeck A/S